Summary The prevalence of human papillomavirus (HPV) infection and other risk factors were studied in a high risk area for cervical cancer (Greenland) Epidemiological research has long pointed to cancer of the cervix uteri as a sexually transmitted disease (Brinton & Fraumeni, 1986) . For more than a decade, human papillomavirus (HPV) has been suggested to play an important role in cervical carcinogenesis (zur Hausen, 1989) . Not only has HPV DNA been detected in more than 90% of all cervical carcinoma samples tested, but it has also recently been shown that human keratinocytes immortalised with HPV DNA, turn malignant after prolonged cultivation (Hurlin et al., 1991; Pecoraro et al., 1991) . If HPV is a main causal agent, one would anticipate a geographical accordance between incidence of cervical cancer and prevalence of HPV infection. On this background we were surprised that our population-based comparison showed that the prevalence of HPV 16/18 detection was higher in Denmark (13.0%) than in Greenland (8.8%) in spite of the cervical cancer incidence being five times higher in Greenland (Kjaer et al., 1988) . By contrast, the high risk Greenlandic women were characterised by e.g. a higher number of sexual partners and earlier age at first intercourse compared with Danish women (Kjaer et al., 1989) . Because of the surprising lack of correspondence between HPV 16/18 prevalence and incidence of cervical cancer and in view of the further development of new DNA hybridisation techniques, we decided to undertake a renewed comparative study in the same geographical areas. In addition, we reinvestigated the association between HPV and HSV infection and the number of sexual partners like in the previous investigation (Kjaer et al., 1990 
Epidemiological research has long pointed to cancer of the cervix uteri as a sexually transmitted disease (Brinton & Fraumeni, 1986) . For more than a decade, human papillomavirus (HPV) has been suggested to play an important role in cervical carcinogenesis (zur Hausen, 1989) . Not only has HPV DNA been detected in more than 90% of all cervical carcinoma samples tested, but it has also recently been shown that human keratinocytes immortalised with HPV DNA, turn malignant after prolonged cultivation (Hurlin et al., 1991; Pecoraro et al., 1991) . If HPV is a main causal agent, one would anticipate a geographical accordance between incidence of cervical cancer and prevalence of HPV infection. On this background we were surprised that our population-based comparison showed that the prevalence of HPV 16/18 detection was higher in Denmark (13.0%) than in Greenland (8.8%) in spite of the cervical cancer incidence being five times higher in Greenland (Kjaer et al., 1988) . By contrast, the high risk Greenlandic women were characterised by e.g. a higher number of sexual partners and earlier age at first intercourse compared with Danish women (Kjaer et al., 1989) . Because of the surprising lack of correspondence between HPV 16/18 prevalence and incidence of cervical cancer and in view of the further development of new DNA hybridisation techniques, we decided to undertake a renewed comparative study in the same geographical areas. In addition, we reinvestigated the association between HPV and HSV infection and the number of sexual partners like in the previous investigation (Kjaer et al., 1990 (Kissmeyer-Nielsen et al., 1971 ).
The cumulative incidence rate of cervical cancer is 5.7 times higher in Greenland than in Denmark for women 20-39 years of age (Kjaer et al., 1988) .
The study comprised 150 women (20-39 years of age)
born in Greenland and with residence in Nuuk, and 150
women (20-39 years old) born in Denmark, resident in the municipality of Nyk0bing Falster. The study populations were drawn at random from the computerised Danish Central Population Register. The procedure of enrolment was identical to that of the first study, and a detailed description has been provided previously (Kjaer et al., 1988) . In Greenland, 17 women had moved out of the area prior to enrolment, leaving 133 eligible for study. Of these, 129 women (97.0%) were included (Table I) , three (2.3%) did not want to participate, and one women (0.8%) could not be reached. In Denmark, a total of 144 women were eligible for investigation (six had moved before contact). We succeeded in including 126 women (87.5%) (Table I) , 11 (7.6%) did not want to participate, and seven (4.9%) could not be con- tacted. (Greenland) , and study participants in the first study (1986) and in the second study (1988) Nykobing Faister, Denmark Nuuk, Greenland Totalfemale 1. study (1986) 2. study (1988) Totalfemale 1. study (1986) (Dartmann et al., 1986; Seedorf et al., 1985; Cole & Danos, 1987; Cole & Streek, 1986) . The localisation of the primers were such that amplimers of the respective HPV types could be identified according to their size on agarose gels (Whitcomb et al., 1989) .
Amplification reactions were performed in groups of 20 samples, each time including a positive (100 pg purified HPV plasmid DNA plus 100 ng carrier DNA) as well as a negative (sperm DNA) control.
Cells obtained from each cervical smear were lysed with SDS and digested with Proteinase K. After subsequent phenol extraction, the DNA was precipitated and pellets resuspended at 50 fg ml-'.
The PCR method was performed essentially as described by Whitcomb et al. (1989) . Fifty to 100 ng of each cellular DNA sample was added to aliquots of the amplification solution consisting of 50 mM Tris-HCl (pH 8.3), 50 mM KCI, 7 mM MgC12, 170 ,ug ml-' BSA, 10 mM 2-mercapto-ethanol and dATP, dCTP, dTTP, dGTP, each at 1.2 mM.
Primer pairs (12.51tg ml-') were added to a final concentration of 6 pmoles. After denaturation (94°C for 4 min), samples were cooled and Taq-polymerase (Cetus, 1 unit) added. Samples were subjected to 30 cycles of amplification (1 min at 89°C, followed by 1 min at 63°C) using a PerkinElmer Cetus DNA Thermal Cycler.
Amplified products of each sample (8 sl aliquots) were electrophoresed on agarose gels (2%) and the gels then stained with ethidium bromide for visualisation of amplified DNA sequences which were subsequently blotted onto nylon membranes. Hybridisation of these Southern blots were performed using stringent conditions and the respective HPV DNA (8 kb genome) as radiolabelled probe. Washing of the blots was done using the same conditions. Each sample was tested for the four HPV DNAs in four separate amplification reactions.
Herpes simplex virus
The assay for HSV type specific antibodies was done by microtest-plate ELISA using the general technical principles described by Vestergaard (1986) . Each serum was investigated by indirect blocking ELISA (Vestergaard & Grauballe, 1979) , and competitive ELISA (Najem et al., 1983) . The type-specificity of the competitive ELISA was improved by additional blocking of HSV-type-common epitopes with type-heterologous rabbit immunoglobulins before competition.
Statistical analyses
To describe the variation in prevalence of possible risk factors of cervical cancer between Denmark and Greenland, prevalence odds ratios were used. Using prevalence risk ratios would intuitively be more straightforward but we need to standardise for age since the age distribution differs between Denmark and Greenland. The odds ratio has better statistical properties and is usually considered to be a more stable measure than the risk ratio. The age standardised odds ratio was calculated by fitting the logistic model with country as response variable and age (in 5-year age groups) and the factor in question as explaining factors.
For Nuuk/Godthab (14.7%) . Table IV shows the age-standardised prevalence odds ratios (Greenland/Denmark) of specific HPV types diagnosed by means of PCR. The HPV 16 detection rate was higher in Denmark (24.6%) than in Greenland (20.2%) and a similar pattern was seen for HPV 18 (Denmark: 19.8% and Greenland: 14.7%). However, none of these differences were statistically significant. HPV 11 seemed to be a little more prevalent in Greenland (6.2%) compared to Denmark (3.2%), whereas the frequency of HPV 33 infection was nearly identical in the two areas. The most pronounced difference was found in the prevalence of women with multiple HPV infections which was around 60% lower in Greenland compared to Denmark (P = 0.03), when adjustment was Figure 2 , the HPV results of the first Greenland/ Denmark study from 1986 as well as the second study from 1988 are presented schematically. The level of detection seemed to be rather different for the three different methods used. By PCR, we detected the highest rate, by filter in situ hybridisation it was lower, and by ViraPap/ViraType we observed the significantly lowest rate. However, the relationship between the detection rates in Denmark and Greenland was the same, independently of the detection method. Also the frequency distribution of specific types was identical in the two study areas from method to method. weaker than the positive controls included in the commercial kit, the material was sent to Dr A.T. Lorincz at Life Technologies, Inc., Gaithersburg, USA, who reviewed all the ViraPap and ViraType filters:' The results of this review were in agreement with the results presented here. The prevalence of HPV (around 5%) detected by this method in both areas, has also been found among women in Spain and Colombia (N. Munoz & F.X. Bosch; personal communication). However, several investigations including our own previous comparison between Denmark and Greenland indicate a higher prevalence of HPV in the general population when using other HPV detection methods.
The results of the PCR test show that the frequency of any HPV detection is a little higher in Greenland (43.4%) compared to Denmark (38.9%). However, the prevalence of HPV infections yielding a strong positive signal (>4+) is 1.6 times higher in Danish women (23.0%) than in Greenlandic women (14.7%), and vice versa with the weak signal. This could suggest that immune suppression is occurring in women from Greenland, presumably because of high levels of exposure to HPV from sexual contact.
Thus, the results of both diagnostic methods (ViraPap/ Type and PCR) are in line with our previous populationbased cross-sectional study, in which we found a 1.5 times higher prevalence of HPV 16/18 in Denmark compared to Greenland using filter in situ hybridisation. Although the overall level of the HPV detection rate is different for the various hybridisation methods, the interrelationship between Denmark and Greenland is consistent and independent of the diagnostic method used. Nor does the inclusion of analysis for HPV types 31/33/35 reveal a difference between the two areas. Hypothetically, HPV DNA detection may have different implications in the two areas. In Denmark it may reflect transient, newly acquired infection, whereas in Greenland it may be more indicative of chronic persistent infection.
Results from an analysis of HPV detectability in relation to number of recent partners (i.e. partners in the last month) may suppoort this hypothesis (Table X) . The odds for having HPV 16 or any HPV type detected in the case of no sexual partners in the last month was respectively 3.2 and 5.6 times higher in Greenland than in Denmark. By contrast, the HPV detectability was similar in the two areas among women with > 1 sexual partner in the last month.
However, apart from this it cannot be excluded that misclassification of HPV infection has influenced our results. Recently, Franco (1991) has discussed the role of misclassification and has concluded that even low levels of such a misclassification may lead to substantially erroneous estimates of the HPV prevalence. DNA hybridisation methods are currently the best diagnostic tool for detection of HPV shedding. The sensitivities of dot blot hybridisation and filter in situ hybridisation have been compared (Cornelissen et al., 1988) . Several studies have also compared the filter in situ method with Southern blot hybridisation (Schneider et al., 1986; de Villiers et al., 1987; Caussy et al., 1988; Melchers et al., 1988) . However, findings from these comparisons are equivocal. Also studies using Southern blot have reported rather heterogenous HPV prevalence rates and also interlaboratory variability has been demonstrated even between experienced laboratories (Brandsma et al., 1989) . It can be concluded that although studies comparing methods are beginning to appear, we still know only little about the validity of the tests in terms of ability to categorise truly infected individuals as test-positive and non-infected as negative.
Amplification of the viral genome through a polymerase chain reaction is thought to be the most sensitive method for the detection of HPV. However, the estimates of HPV prevalence in normal women has varied from 0% to around 70% (Young et al., 1989; van den Brule et al., 1989; Manos et al., 1990) . One of the most substantial problems in this field has been the risk of laboratory contamination. Greenland/Denmark study (Kjaer et al., 1988 HPV and other genital infections in relation to number of sexual partners
The previously reported lack of relationship between sexual activity in terms of number of sexual partners and the risk of detection of HPV by filter in situ hybridisation (Kjaer et al., 1990 ) is also found when PCR is used as the diagnostic method. Although these findings are conforming to those of early hybridisation studies (Villa et al., 1989; Reeves et al., 1989; Kiviat et al., 1989) , it is still somewhat surprising in view of the general idea of HPV being mainly a sexually transmitted disease. The possibility of a non-sexual transmission cannot be excluded. However, it is noteworthy that some more recent hybridisation studies tend to find a clear correlation between HPV DNA detection and number of sexual partners (Ley et al., 1991 An alternative explanation for the lack of association could also be that the answers to the sexual questions are not valid. However, this is not likely to be the case in this study.
The information on sexual habits and HPV diagnosis were gathered independently, and thus the interviewers had no knowledge about the infection status of the women. Furthermore, the high consistency in the results from the first and second survey dealing with two independent, randomly chosen population-samples also speak against a pronounced misclassification of the women regarding number of partners.
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